Cellectar Biosciences Inc (CLRB.OQ)
CLRB.OQ on NASDAQ Stock Exchange Capital Market
2.30USD
16 Nov 2018
2.30USD
16 Nov 2018
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$2.30
$2.30
Open
$2.24
$2.24
Day's High
$2.31
$2.31
Day's Low
$2.24
$2.24
Volume
2,616
2,616
Avg. Vol
53,669
53,669
52-wk High
$15.90
$15.90
52-wk Low
$2.03
$2.03
About
Cellectar Biosciences, Inc., formerly Novelos Therapeutics, Inc., is a clinical stage biopharmaceutical company. The Company is engaged in developing phospholipid ether-drug conjugates (PDCs) for the treatment and diagnostic imaging of cancer. Its research and development program is based on its PDC cancer targeting delivery... (more)
Overall
| Beta: | 1.02 |
| Market Cap(Mil.): | $23.88 |
| Shares Outstanding(Mil.): | 13.92 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CLRB.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 31.23 | 33.59 |
| EPS (TTM): | -1.24 | -- | -- |
| ROI: | -103.68 | 15.57 | 15.05 |
| ROE: | -105.20 | 16.94 | 16.62 |
Estimates